For instance, exosomes released from HepG2 cells treated with ezetimibe do not induce inflammasome activation or IL-1β secretion, suggesting that exosomal cargo composition is sensitive to the metabolic state of the tumor cells [240]. Here, IL1B is linked to neoplasm.